Schistosomicidal and antifecundity effects of oral treatment of synthetic endoperoxide N-89

Parasitology International

Volumn 60, Issue 3, 2011, Pages 231-236

  Taniguchi, Toshie ^a   Kumagai, Takashi ^a   Shimogawara, Rieko ^a   Ichinose, Shizuko ^a   Hiramoto, Akiko ^b   Sato, Akira ^b   Morita, Masayuki ^b   Nojima, Masatomo ^c   Kim, Hye Sook ^b   Wataya, Yusuke ^b   Ohta, Nobuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Fecundity; Hemozoin; N 89; Schistosoma mansoni; Worm burden

Indexed keywords

1,2,6,7 TETRAOXASPIRO[7.11]NONADECANE; ANTIPARASITIC AGENT; N 89; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMULUM; TRANSMISSION ELECTRON MICROSCOPY; WORM INFECTION;

ADMINISTRATION, ORAL; ANIMALS; FEMALE; HEMEPROTEINS; HETEROCYCLIC COMPOUNDS, 2-RING; HUMANS; MALE; MICE; MICE, INBRED BALB C; PARASITE EGG COUNT; PARASITIC SENSITIVITY TESTS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES; SPIRO COMPOUNDS; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; MAMMALIA; MURINAE; MUS; SCHISTOSOMA MANSONI;

EID: 79959527103     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2011.02.007     Document Type: Article

References (37)

1. Chitsulo L., Engels D., Montresor A., Savioli L. The global status of schistosomiasis and its control. Acta Trop 2000, 77:41-51.
2. Esrey S.A., Potash J.B., Roberts L., Shiff C. Effects of improved water supply and sanitation on ascariasis, diarrhoea, dracunculiasis, hookworm infection, schistosomiasis, and trachoma. Bull World Health Organ 1991, 69:609-621.
3. McCullough F.S., Gayral P., Duncan J., Christie J.D. Molluscicides in schistosomiasis control. Bull World Health Organ 1980, 58:681-689.
4. Fallon P.G., Tao L.F., Ismail M.M., Bennett J.L. Schistosome resistance to praziquantel: fact or artifact?. Parasitol Today 1996, 12:316-320.
5. Liang Y.S., Coles G.C., Doenhoff M.J., Southgate V.R. In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. Int J Parasitol 2001, 31:1227-1235.
6. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 1999, 60:932-935.
7. Xiao S., Tanner M., N'Goran E.K., Utzinger J., Chollet J., Bergquist R., et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 2002, 82:175-181.
8. Hamed M.A., Hetta M.H. Efficacy of citrus reticulata and mirazid in treatment of Schistosoma mansoni. Mem Inst Oswaldo Cruz 2005, 100:771-778.
9. Angelucci F., Sayed A.A., Williams D.L., Boumis G., Brunori M., Dimastrogiovanni D., et al. Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects. J Biochem 2009, 284:28977-28985.
10. Dhingra V., Rao K.V., Narasu M.L. Current status of artemisinin and its derivatives as antimalarial drugs. Life Sci 2000, 66:279-300.
11. Ridder S., Kooy F., Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing counties. J Ethnopharmacol 2008, 120:302-314.
12. Krishna S., Bustamante L., Haynes R.K., Staines H.M. Artemisinins: their growing importance in medicine. Trends Pharmacol Sci 2008, 29:520-527.
13. Jonathan L.V., Sarah A.B., Reto B., Susan A.C., Francis C.K.C., Jacques C., et al. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 2004, 430:900-904.
14. SH L., Kumagai T., Ai Q.H., Yan X.L., Ohmae H., Yabu Y., et al. Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitol Int 2006, 55:63-68.
15. Utzinger J., Xiao S., Keiser J., Chen M., Zheng J., Tanner M. Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr Med Chem 2001, 8:1841-1860.
16. Xiao S.H., Mei J.Y., Jiao P.Y. Schistosoma japonicum-infected hamsters (Mesocricetus auratus) used as a model in experimental chemotherapy with praziquantel, artemether, and OZ compounds. Parasitol Res 2011, 108:431-437.
17. Xiao S.H. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop 2005, 96:153-167.
18. Stelma F.F., Talla I., Sow S., Kongs A., Niang M., Polman K., et al. Efficacy and side effects of praziquantel in an endemic focus of Schistosoma mansoni. Am J Trop Med Hyg 1995, 53:167-170.
19. Goennert R., Andrews P. Praziquantel, a new broad-spectrum antischistosomal agent. Z Parasitenk 1977, 52:129-150.
20. Xiao S.H., Jennifer K., Jacques C., Juorg U., Yuxiang D., Yvette E., et al. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob Agents Chemother 2007, 51:1440-1445.
21. Xiao S.H., Utzinger J., Chollet J., Tanner M. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both. Int J Parasitol 2006, 36:957-964.
22. Inyang-Etoh P.C., Ejezie G.C., Useh M.F., Inyang-Etoh E.C. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria. Trans R Soc Trop Med Hyg 2009, 103:38-44.
23. Aly N.S., Hiramoto A., Sanai H., Hiraoka O., Hiramoto K., Kataoka H., et al. Proteome analysis of new antimalarial endoperoxide against Plasmodium falciparum. Parasitol Res 2007, 100:1119-1124.
24. Kim H.S., Nagai Y., Ono K., Begum K., Wataya Y., Hamada Y., et al. Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J Med Chem 2001, 44:2357-2361.
25. Kim H.S., Begum K., Ogura N., Wataya Y., Nonami Y., Ito T., et al. Antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes and 1,2,5-trioxacycloalkanes. J Med Chem 2003, 46:1957-1961.
26. Sabah A.A., Fletcher C., Webbe G., Doenhoff M.J. Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 1986, 61:294-303.
27. Wang W., Itoh S., Matsuda A., Ichinose S., Shinomiya K., Hata Y., et al. Influences of mechanical properties and permeability on chitosan nano/microfiber mesh tubes as a scaffold for nerve regeneration. J Biomed Mater Res A 2008, 84:557-566.
28. Shaw M.K., Erasmus D.A. Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel. Parasitology 1987, 94:243-254.
29. Oliveir M.F., d' Avila J.C.P., Torres C.R., Oliveira P.L., Tempone A.J., Rumjanek F.D., et al. Haemozoin in Schistosoma mansoni. Mol Biochem Parasitol 2000, 111:217-221.
30. Oliveira M.F., d' Avila J.C., Tempone A.J., Soares J.B., Rumjanek F.D., Fereira-P A., et al. Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection. J Infect Dis 2004, 190:843-852.
31. Correa Soares J.B., Menezes D., Vannier-Santos M.A., Ferreira-Perreira A., Almeida G.T., Venancio T.M., et al. Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols. PLoS Negl Trop Dis 2009, 3:e477.
32. Xiao S., Shen B., Chollet J., Utzinger J., Tanner M. Tegumental changes in adult Schistosoma mansoni harbored in mice treated with artemether. J Parasitol 2000, 86:1125-1132.
33. Kumagai T., Osada Y., Kanazawa T. 2-Cys peroxiredoxins from Schistosoma japonicum: the expression profile and localization in the life cycle. Mol Biochem Parasitol 2006, 149:135-143.
34. Kumagai T., Osada Y., Ohta N., Kanazawa T. Peroxiredoxin-1 from Schistosoma japonicum functions as a scavenger against hydrogen peroxide but not nitric oxide. Mol Biochem Parasitol 2009, 164:26-31.
35. Zussman R.A., Bauman P.M., Petruska J.C. The role of ingested hemoglobin in the nutrition of Schistosoma mansoni. J Parasitol 1970, 56:75-79.
36. Lawrence J.D. The ingestion of red blood cells by Schistosoma mansoni. J Parasitol 1973, 59:60-63.
37. Sauer M.C.V., Senft A.W. Properties of a proteolytic enzyme from Schistosoma mansoni. Comp Biochem Physiol 1972, 42B:205-220.